Global economic burden of Chagas disease: a computational simulation model
Top Cited Papers
- 1 April 2013
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 13 (4) , 342-348
- https://doi.org/10.1016/s1473-3099(13)70002-1
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- The economic burden of Clostridium difficileClinical Microbiology & Infection, 2012
- Trypanosoma cruzi and Chagas' Disease in the United StatesClinical Microbiology Reviews, 2011
- The Potential Economic Value of a Trypanosoma cruzi (Chagas Disease) Vaccine in Latin AmericaPLoS Neglected Tropical Diseases, 2010
- Rotavirus Infections and VaccinesPediatric Drugs, 2010
- Chagas disease: A Latin American health problem becoming a world health problemActa Tropica, 2010
- The Costs of Preventing and Treating Chagas Disease in ColombiaPLoS Neglected Tropical Diseases, 2008
- Chagas diseasePostgraduate Medical Journal, 2006
- Screening the United States Blood Supply for West Nile Virus: A Question of Blood, Dollars, and SensePLoS Medicine, 2006
- Life expectancy analysis in patients with Chagas' disease: prognosis after one decade (1973–1983)International Journal of Cardiology, 1985